Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 45.33 | -32.75 |
PEG Ratio (TTM) | -1.28 | -2.62 |
P/S Ratio (TTM) | N/A | 35.22 |
P/B Ratio (TTM) | 1.77 | 6.92 |
P/FCF Ratio (TTM) | -43.83 | -188.65 |
Price to 5YR AVG Earnings Ratio | N/A | -29.46 |
Price to 5YR AVG FCF Ratio | N/A | -26.95 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.67% | 47.25% |
ROE (TTM) | 3.94% | -531.49% |
Net Profit Margin (TTM) | N/A | -264.51% |
ROIC 5YR AVG | N/A | 831.75% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -37.95% | 556.25% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -47.98% | -9,229.76% | N/A |
Cash Flow | 10.11% | -7,474,399.23% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.27 | 4.81 |
Quick Ratio (TTM) | 0.27 | 24.14 |
D/E Ratio (TTM) | 0.19 | 0.23 |
Interest Coverage (TTM) | -0.89 | 2.74 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 3.58 | 21.22 |
LTL to 5YR AVG FCF | N/A | -1.27 |
Shares Outstanding Growth 5YR AVG | N/A | 515.61% |